{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:41Z","timestamp":1791928961144,"version":"4.3.4"},"reference-count":54,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"10","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,8,14]]},"DOI":"10.1167\/iovs.67.10.35","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:30:51Z","timestamp":1786710651000},"page":"35","source":"Crossref","is-referenced-by-count":0,"title":["Gut Microbial Metabolite Indole-3-Acetic Acid Exerts Protective Effects by Regulating Orbital Fibroblast Fibrosis in Thyroid Eye Disease"],"prefix":"10.1167","volume":"67","author":[{"given":"Yiyan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Affiliated Hospital of Zunyi Medical University, Zunyi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fagang","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"5","key":"bib1","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/joim.13524","article-title":"Current concepts regarding Graves\u2019 orbitopathy","volume":"292","author":"Bartalena","year":"2022","journal-title":"J Intern Med"},{"issue":"2","key":"bib2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"suppl_1","key":"bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/clinem\/dgac045","article-title":"It takes two to tango: IGF-I and TSH receptors in thyroid eye disease","volume":"107","author":"Girnita","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"bib4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.survophthal.2021.08.010","article-title":"Thinking inside the box: current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease","volume":"67","author":"Gupta","year":"2022","journal-title":"Surv Ophthalmol"},{"issue":"pt 1","key":"bib5","doi-asserted-by":"crossref","first-page":"147867","DOI":"10.1016\/j.ijbiomac.2025.147867","article-title":"Bispecific aptamers target thyrotropin receptor (TSHR) and insulin growth factor-1 receptor (IGF-1R) for the improvement of orbital fibroblasts activation in the treatment of thyroid-associated ophthalmopathy","volume":"330","author":"Xie","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"bib6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1089\/thy.2023.0309","article-title":"Yes-associated protein mediates the transition from inflammation to fibrosis in Graves\u2019 orbitopathy","volume":"33","author":"Ko","year":"2023","journal-title":"Thyroid."},{"issue":"2","key":"bib7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41433-019-0731-5","article-title":"Fibrosis in dysthyroid eye disease","volume":"34","author":"Ludgate","year":"2020","journal-title":"Eye (Lond)"},{"issue":"17","key":"bib8","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/cells13171493","article-title":"A review of pathophysiology and therapeutic strategies targeting TGF-\u00df in Graves\u2019 ophthalmopathy","volume":"13","author":"Chang","year":"2024","journal-title":"Cells"},{"issue":"18","key":"bib9","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"bib10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1210\/clinem\/dgad637","article-title":"Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity","volume":"109","author":"Douglas","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"bib11","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/thy.2023.0167","article-title":"Medical therapy in patients with moderate to severe, steroid-resistant, thyroid eye disease","volume":"33","author":"Toro-Tobon","year":"2023","journal-title":"Thyroid"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ajo.2023.12.001","article-title":"Reactivation after teprotumumab treatment for active thyroid eye disease","volume":"263","author":"Hwang","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"bib13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/ard-2024-225735","article-title":"Microbiome research in autoimmune and immune-mediated inflammatory diseases: lessons, advances and unmet needs","volume":"84","author":"Scher","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"bib14","doi-asserted-by":"publisher","first-page":"103654","DOI":"10.1016\/j.autrev.2024.103654","article-title":"Exploring the role of gut microbiome in autoimmune diseases: a comprehensive review","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"issue":"3","key":"bib15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.66.3.5","article-title":"Butyrate ameliorates Graves\u2019 orbitopathy through regulating orbital fibroblast phenotypes and gut microbiota","volume":"66","author":"Ouyang","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s40618-022-01902-7","article-title":"The role and molecular mechanism of gut microbiota in Graves\u2019 orbitopathy","volume":"46","author":"Li","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"Gut microbiota in experimental murine model of Graves\u2019 orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"issue":"8","key":"bib18","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/ceo.14291","article-title":"Changes in the gut microbiota of patients with Graves\u2019 orbitopathy according to severity grade","volume":"51","author":"Zhang","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"1413890","DOI":"10.3389\/fendo.2024.1413890","article-title":"Exploring gut microbiota and metabolite alterations in patients with thyroid-associated ophthalmopathy using high-throughput sequencing and untargeted metabolomics","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"bib20","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s40618-019-1010-9","article-title":"Alterations in the intestinal microbiota of patients with severe and active Graves\u2019 orbitopathy: a cross-sectional study","volume":"42","author":"Shi","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"bib21","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1210\/clinem\/dgad030","article-title":"Gut microbiome associated with graves disease and Graves orbitopathy: the INDIGO Multicenter European Study","volume":"108","author":"Biscarini","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7950","key":"bib22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"issue":"1","key":"bib23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.chom.2018.11.009","article-title":"A diet-sensitive commensal Lactobacillus strain mediates TLR7-dependent systemic autoimmunity","volume":"25","author":"Zegarra-Ruiz","year":"2019","journal-title":"Cell Host Microbe"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"1173481","DOI":"10.3389\/fendo.2023.1173481","article-title":"Intestinal permeability is associated with aggravated inflammation and myofibroblast accumulation in Graves\u2019 orbitopathy: the MicroGO study","volume":"14","author":"Fenneman","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"bib25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","article-title":"2021 update on thyroid-associated ophthalmopathy","volume":"45","author":"Neag","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"bib26","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s40618-025-02593-6","article-title":"Tryptophan metabolites exert potential therapeutic activity in Graves\u2019 orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation","volume":"48","author":"Yang","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"bib27","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves\u2019 Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"bib28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"bib29","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","article-title":"Gut microbiota-derived metabolites as central regulators in metabolic disorders","volume":"70","author":"Agus","year":"2021","journal-title":"Gut"},{"issue":"7","key":"bib30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S2213-8587(25)00066-X","article-title":"Thyroid eye disease (Graves\u2019 orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","volume":"13","author":"Wiersinga","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"bib31","doi-asserted-by":"publisher","first-page":"e220189","DOI":"10.1530\/ETJ-22-0189","article-title":"Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association","volume":"11","author":"Burch","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"6","key":"bib32","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.3390\/ijms22062952","article-title":"JNK and p38 inhibitors prevent transforming growth factor-\u00df1-induced myofibroblast transdifferentiation in human Graves\u2019 orbital fibroblasts","volume":"22","author":"Hou","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"bib33","doi-asserted-by":"publisher","first-page":"101620","DOI":"10.1016\/j.beem.2022.101620","article-title":"Pathophysiology of thyroid-associated orbitopathy","volume":"37","author":"Lee","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"bib34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1756-9966-31-46","article-title":"A selective aryl hydrocarbon receptor modulator 3,3'-Diindolylmethane inhibits gastric cancer cell growth","volume":"31","author":"Yin","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"issue":"13","key":"bib35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1167\/iovs.65.13.40","article-title":"Tapinarof, an aryl hydrocarbon receptor ligand, mitigates fibroblast activation in thyroid eye disease: implications for novel therapy","volume":"65","author":"Patrick","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"bib36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1039\/C4TX00236A","article-title":"Ah receptor pathway intricacies; signaling through diverse protein partners and DNA-motifs","volume":"4","author":"Jackson","year":"2015","journal-title":"Toxicol Res (Camb)"},{"issue":"13","key":"bib37","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1111\/bph.15806","article-title":"Aggravation of pulmonary fibrosis after knocking down the aryl hydrocarbon receptor in the insulin-like growth factor 1 receptor pathway","volume":"179","author":"Wu","year":"2022","journal-title":"Br J Pharmacol"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"106886","DOI":"10.1016\/j.intimp.2020.106886","article-title":"Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic target","volume":"88","author":"Shi","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"7612","key":"bib39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","article-title":"Human gut microbes impact host serum metabolome and insulin sensitivity","volume":"535","author":"Pedersen","year":"2016","journal-title":"Nature"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"123191","DOI":"10.1016\/j.lfs.2024.123191","article-title":"Indole-3-acetic acid attenuates pulmonary fibrosis by modulating lung microbiota, inhibiting fibroblast activation, and alleviating alveolar epithelial cell senescence","volume":"359","author":"Zhuo","year":"2024","journal-title":"Life Sci"},{"issue":"1","key":"bib41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41421-024-00709-5","article-title":"Gut microbiota-derived indole-3-acetic acid suppresses high myopia progression by promoting type I collagen synthesis","volume":"10","author":"Li","year":"2024","journal-title":"Cell Discov"},{"issue":"1","key":"bib42","doi-asserted-by":"publisher","first-page":"2307568","DOI":"10.1080\/19490976.2024.2307568","article-title":"Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation","volume":"16","author":"Min","year":"2024","journal-title":"Gut Microbes"},{"issue":"9","key":"bib43","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"bib44","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor-\u00df in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J Exp Med"},{"issue":"7","key":"bib45","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1167\/iovs.08-2443","article-title":"Imatinib mesylate and AMN107 inhibit PDGF-signaling in orbital fibroblasts: a potential treatment for Graves\u2019 ophthalmopathy","volume":"50","author":"van Steensel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"412158","DOI":"10.1155\/2014\/412158","article-title":"Markers of inflammation and fibrosis in the orbital fat\/connective tissue of patients with Graves\u2019 orbitopathy: clinical implications","volume":"2014","author":"Pawlowski","year":"2014","journal-title":"Mediators Inflamm"},{"key":"bib47","first-page":"927","article-title":"The protective effect of antioxidants on orbital fibroblasts from patients with Graves\u2019 ophthalmopathy in response to oxidative stress","volume":"19","author":"Tsai","year":"2013","journal-title":"Mol Vis"},{"issue":"12","key":"bib48","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1016\/j.ajpath.2016.08.017","article-title":"The aryl hydrocarbon receptor and its ligands inhibit myofibroblast formation and activation: implications for thyroid eye disease","volume":"186","author":"Woeller","year":"2016","journal-title":"Am J Pathol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"108971","DOI":"10.1016\/j.exer.2022.108971","article-title":"Botox-A improves the thyroid-associated ophthalmopathy (TAO) orbital fibroblast activation through inhibiting the TGF-\u00df\/Smad signaling","volume":"217","author":"Qi","year":"2022","journal-title":"Exp Eye Res"},{"issue":"1","key":"bib50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40662-024-00401-5","article-title":"An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-\u00df1 induced calcium response in an in vitro model of thyroid eye disease","volume":"11","author":"Chen","year":"2024","journal-title":"Eye Vis (Lond)"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"111780","DOI":"10.1016\/j.mce.2022.111780","article-title":"The miR-103a-3p\/TGFBR3 axis regulates TGF-\u00df-induced orbital fibroblast activation and fibrosis in thyroid-eye disease","volume":"559","author":"Xie","year":"2023","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"bib52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","article-title":"Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites","volume":"181","author":"Miao","year":"2024","journal-title":"Br J Pharmacol"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2022.03.025","article-title":"Host\/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling","volume":"184","author":"Tan","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.freeradbiomed.2023.07.014","article-title":"Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy","volume":"207","author":"Wang","year":"2023","journal-title":"Free Radic Biol Med"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.10.35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:18Z","timestamp":1791927138000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.10.35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.10.35","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,14]]}}}